From these findings we conclude that the expression level of Klf4 by itself may not be sufficient to exert a robust effect, rather, Nanog might play a more potentiating role in sphere formation in metastatic pancreatic cancer. The gene discussed is NANOG; the disease is familial pancreatic carcinoma.